In conclusion, we obtained valuable information about KMT2C in osteosarcoma: we found a nuclear-cytoplasmic trafficking that could have a role in osteosarcoma carcinogenesis and progression probably linked to the consequent change of its function. The gene discussed is KMT2C; the disease is osteosarcoma.